septemb
novel
human
coronaviru
hcovemc
report
health
author
two
case
acut
respiratori
syndrom
renal
failur
recent
updat
identifi
total
confirm
case
human
infect
includ
death
suggest
mortal
rate
individu
histori
recent
travel
middl
east
identif
cluster
coronaviru
case
indic
hcovemc
transmit
human
human
rais
concern
possibl
outbreak
viru
similar
one
caus
relat
viru
sever
acut
respiratori
syndromerel
coronaviru
sarscov
sarscov
origin
china
spread
throughout
asia
contin
affect
peopl
overal
mortal
outbreak
estim
mortal
rate
hcovemc
assess
certainli
could
pathogen
sarscov
hcovemc
belong
genu
betacoronaviru
sarscov
howev
hcovemc
close
relat
bat
coronavirus
lineag
sarscov
lineag
less
amino
acid
sequenc
ident
conserv
replicas
domain
sarscov
hcovemc
anoth
import
differ
two
virus
use
host
cell
receptor
infect
inde
clearli
shown
human
angiotensinconvert
receptor
use
sarscov
hcovemc
receptor
dipeptidyl
peptidas
recent
identifi
hcovemc
receptor
receptor
conserv
among
differ
speci
bat
human
partial
explain
larg
host
rang
hcovemc
somewhat
surpris
coronavirus
gener
show
strict
host
specif
recent
identif
crystal
structur
hcovemc
proteas
suggest
widespectrum
cov
proteas
inhibitor
could
block
catalyt
site
current
proven
antivir
treatment
hcovemc
virus
reli
host
factor
replic
often
hijack
cellular
process
initi
respons
infect
ensur
effici
replic
target
cellular
respons
shown
inhibit
viral
replic
furthermor
immunomodulatori
drug
reduc
excess
host
inflammatori
respons
respiratori
virus
seen
influenza
viru
infect
therapeut
benefit
review
refer
sever
genomebas
drug
repurpos
strategi
success
identifi
known
drug
could
reus
treat
lung
cancer
inflammatori
bowel
diseas
influenza
viru
infect
approach
advantag
acceler
treatment
avail
could
crucial
case
outbreak
emerg
pathogen
overal
differ
viral
sequenc
host
cell
receptor
host
rang
indic
hcovemc
sarscov
may
distinct
strategi
interact
host
fact
could
impact
treatment
strategi
begin
assess
question
compar
host
respons
human
cell
hcovemc
sarscov
infect
use
global
transcriptom
profil
goal
gain
rapid
comprehens
assess
host
respons
hcovemc
infect
could
guid
research
emerg
viru
importantli
use
inform
comput
predict
antivir
treatment
identifi
broad
downregul
antigen
present
pathway
may
import
vivo
develop
adapt
immun
respons
character
hcovemc
sought
cell
line
mimic
human
airway
cell
deriv
epitheli
cell
line
human
conduct
airway
differenti
polar
ciliat
cell
permit
robust
replic
sever
respiratori
virus
includ
sarscov
influenza
viru
respiratori
syncyti
viru
rsv
therefor
cell
infect
hcovemc
use
multipl
infect
moi
result
compar
cell
infect
sarscov
urbani
moi
virus
replic
similar
level
peak
pfu
h
postinfect
hpi
fig
sarscov
previous
shown
maintain
steadi
replic
cell
viabil
hpi
hcovemc
induc
substanti
cytopath
effect
hpi
signific
cell
round
detach
togeth
data
suggest
although
hcovemc
sarscov
exhibit
similar
replic
kinet
elicit
differ
host
respons
lung
epitheli
cell
assess
global
host
transcript
respons
follow
infect
hcovemc
sampl
infect
cell
collect
throughout
time
cours
postinfect
gene
differenti
express
de
compar
timematch
mockinfect
control
determin
use
statist
cutoff
q
valu
absolut
fc
gene
compar
de
gene
cell
infect
sarscov
across
time
cours
use
statist
cutoff
fig
previous
observ
sarscov
abl
replic
activ
surprisingli
small
number
signific
transcript
chang
hpi
de
gene
hpi
gene
hpi
fig
similarli
hcovemc
induc
fewer
transcript
chang
hpi
howev
hcovemc
replic
earli
time
postinfect
induc
chang
sarscov
number
de
gene
rang
hpi
gene
hpi
fig
later
time
postinfect
massiv
host
respons
observ
hcovemc
infect
de
gene
hpi
gene
hpi
sarscov
induc
chang
gene
hpi
maximum
chang
hpi
gene
respect
evalu
similar
transcript
dysregul
hcovemc
sarscov
determin
percentag
overlap
among
de
gene
chang
direct
time
point
fig
intersect
downregul
de
gene
condit
calcul
separ
averag
determin
percentag
intersect
gene
fig
overlap
signatur
late
time
postinfect
singl
viru
high
exampl
gene
de
hcovemc
hpi
also
de
hpi
averag
de
gene
hpi
sarscov
also
de
later
time
postinfect
howev
overlap
sarscov
hcovemc
time
point
low
exampl
de
gene
respons
hcovemc
hpi
also
de
sarscov
time
point
note
intersect
de
gene
two
infect
higher
later
time
postinfect
sarscov
compar
earlier
time
point
hcovemc
averag
hcovemc
signatur
hpi
overlap
signatur
sarscov
hpi
togeth
result
indic
hcovemc
induc
robust
larg
differ
host
respons
compar
induc
sarscov
similar
time
postinfect
howev
chang
induc
hpi
hcovemc
similar
chang
induc
late
sarscov
infect
hpi
late
time
postinfect
hcovemc
induc
drastic
chang
host
transcriptom
de
gene
hpi
andor
hpi
character
late
signatur
compar
fold
chang
fc
express
valu
gene
infect
sarscov
hcovemc
fig
wwwsystemsvirologyorg
gene
express
similarli
sarscovinfect
sampl
later
time
postinfect
gene
express
differ
sarscov
infect
gene
cluster
accord
express
pattern
hcovemc
infect
cell
cluster
iii
contain
gene
upregul
hcovemc
infect
hpi
cluster
ii
iv
contain
downregul
gene
enrich
canon
pathway
cluster
perform
shown
fig
gene
upregul
hcovemc
sarscov
cluster
though
later
sarscov
hcovemc
primarili
relat
viral
recognit
activ
innat
immun
pathway
pathway
activ
interferon
regulatori
factor
irf
cytosol
pattern
recognit
receptor
gene
downregul
virus
cluster
ii
relat
metabol
gene
specif
upregul
hcovemc
statist
enrich
pathway
campmedi
signal
protein
ubiquitin
ubiquitin
involv
innat
immun
antivir
respons
could
repres
interest
mechan
explor
final
gene
specif
downregul
hcovemc
infect
larg
relat
antigen
present
pathway
addit
identifi
canon
pathway
strongli
relat
lymphocyt
signal
process
togeth
data
suggest
hcovemc
may
quickli
move
interfer
element
adapt
immun
respons
contrast
sarscov
downregul
antigen
present
pathway
may
import
implic
develop
adapt
respons
close
examin
chang
pathway
infect
hcovemc
fig
twentytwo
gene
relat
major
histocompat
complex
mhc
class
mhc
class
ii
antigen
present
found
downregul
hcovemc
infect
fig
contrast
vast
major
gene
upregul
sarscov
infect
hpi
fig
interestingli
transcript
regul
mhc
class
mhc
class
ii
ciita
transient
upregul
earli
hcovemc
infect
hpi
respect
gene
downregul
start
hpi
importantli
mhc
class
gene
hlaa
b
c
e
g
class
ii
gene
hladmb
dra
decreas
express
valu
infect
sever
gene
mhc
pathway
includ
proteasom
gene
gene
peptideload
complex
tapbp
downregul
well
gene
invari
chain
belong
mhc
ii
pathway
downregul
gene
within
mhc
ii
pathway
confirm
quantit
revers
transcriptionpcr
rtpcr
gene
test
significantli
decreas
express
hcovemc
sampl
fig
togeth
data
show
hcovemc
sarscov
induc
opposit
regul
entir
antigen
present
pathway
goal
identifi
possibl
drug
modul
host
respons
throughout
infect
earli
time
postinfect
focus
character
earli
transcript
chang
induc
hcovemc
remain
stabl
throughout
infect
among
gene
de
earli
infect
andor
hpi
remain
dysregul
pattern
later
time
postinfect
chose
focu
signatur
avoid
transient
event
specif
one
time
postinfect
exclud
gene
inconsist
express
pattern
across
cours
infect
express
valu
gene
display
fig
avail
wwwsystemsvirologyorg
earli
signatur
enrich
gene
relat
inflammatori
respons
tumor
necrosi
factor
relat
pathway
predict
activ
chemotaxi
leukocyt
see
tabl
supplement
materi
none
gene
de
earli
sarscov
infect
howev
express
gene
chang
hpi
subset
gene
enrich
cell
viabil
molecul
glucocorticoid
receptor
signal
pathway
effort
identifi
potenti
drug
could
block
host
respons
hcovemc
use
earli
signatur
ipa
ingenu
pathway
analysi
upstream
regul
analysi
see
materi
method
identifi
upstream
regul
may
respons
gene
express
chang
observ
earli
infect
upstream
regul
defin
molecul
affect
express
anoth
molecul
includ
transcript
factor
cytokin
microrna
drug
activ
state
regul
predict
base
global
direct
chang
throughout
infect
previous
publish
target
regul
predict
top
five
activ
top
five
downregul
regul
shown
fig
top
five
activ
upstream
regul
includ
gene
molecul
known
induc
activ
inflammatori
gene
also
found
upregul
earli
signatur
top
predict
inhibit
regul
includ
four
kinas
inhibitor
one
corticosteroid
triamcinolon
acetonid
molecul
known
downregul
gene
upregul
earli
across
hcovemc
infect
addit
sever
kinas
inhibitor
includ
glucocorticoid
dexamethason
also
predict
neg
regul
gene
chang
similarli
sarscov
hcovemc
infect
late
time
postinfect
see
tabl
supplement
materi
therefor
hypothes
treat
cell
drug
might
partial
revert
cov
signatur
inhibit
deleteri
host
respons
andor
viral
replic
case
sarscov
hcovemc
test
hypothes
first
analyz
whether
cell
treat
identifi
kinas
inhibitor
gene
express
profil
opposit
one
induc
viral
infect
end
use
connect
map
cmap
databas
drug
transcript
signatur
sever
cell
line
datadriven
tool
allow
identif
molecul
induc
similar
opposit
transcript
chang
rel
queri
signatur
base
connect
score
connect
score
valu
high
posit
score
indic
drug
induc
chang
similar
induc
viral
infect
high
neg
score
indic
drug
revers
express
hcovemc
signatur
cmap
includ
transcript
profil
sever
kinas
inhibitor
includ
two
compound
predict
potenti
neg
regul
viral
respons
ipa
upstream
regul
analysi
connect
score
cell
data
set
supplement
materi
neg
score
cell
line
test
cmap
indic
two
drug
revers
express
profil
hcovemc
signatur
relat
kinas
inhibitor
present
cmap
deriv
neg
score
cell
respect
valid
potenti
effect
identifi
kinas
inhibitor
evalu
abil
top
predict
neg
upstream
regul
interfer
viral
replic
fig
importantli
kinas
inhibitor
predict
regul
gene
de
similarli
sarscov
hcovemc
late
time
postinfect
see
tabl
supplement
materi
could
therefor
inhibit
virus
replic
treat
cell
follow
sarscov
infect
result
signific
decreas
viral
titer
hpi
p
replic
level
similar
interferon
ifn
treat
cell
less
effect
emccov
show
efficaci
posttreat
howev
pretreat
infect
result
signific
decreas
viral
titer
hpi
respect
p
efficaci
sarscov
explain
fact
gene
de
sarscov
infect
predict
regul
kinas
inhibitor
cluster
ii
gene
fig
addit
gene
specif
sarscov
data
shown
gene
specif
hcovemc
cluster
iii
iv
fig
includ
kinas
inhibitor
upstream
neg
regul
see
tabl
addit
host
respons
dynam
sarscov
hcovemc
differ
delay
limit
respons
sarscov
allow
posttreat
effect
contrast
emccov
rapidli
induc
host
express
chang
thu
requir
pretreat
measur
effect
gene
specif
hcovemc
predict
neg
regul
class
molecul
like
gemfibrozil
target
z
import
determin
whether
use
molecul
combin
kinas
inhibitor
like
could
provid
better
inhibit
viral
replic
togeth
data
demonstr
efficaci
two
uniqu
cov
valid
silico
approach
predict
effect
drug
treatment
emerg
virus
hcovemc
isol
patient
die
acut
respiratori
diseas
similar
caus
sarscov
howev
sever
indic
host
respons
two
virus
may
significantli
differ
sever
case
hcovemc
infect
result
renal
failur
rare
observ
sarscov
infect
addit
sarscov
hcovemc
use
cell
receptor
import
differ
genom
sequenc
studi
add
strength
assert
hcovemc
sarscov
inde
even
though
identifi
specif
characterist
sarscov
respons
hcovemc
signatur
hcovemc
induc
robust
specif
transcript
respons
distinct
induc
sarscov
includ
broad
downregul
mhc
molecul
studi
first
global
transcriptom
analysi
cellular
respons
hcovemc
infect
kindler
et
al
perform
rnaseq
human
airway
epithelium
hae
cell
infect
hcovemc
howev
analysi
focus
viral
sequenc
includ
genomewid
analysi
host
respons
howev
use
rtqpcr
quantit
pcr
compar
express
level
set
gene
includ
ifn
rna
sensor
molecul
ifnstimul
gene
isg
follow
infect
hcovemc
sarscov
moi
studi
confirm
sarscov
hcovemc
induc
similar
upregul
rna
sensor
molecul
rigi
two
three
gene
gene
cluster
fig
note
hcovemc
titer
higher
sarscov
hae
cell
wherea
observ
similar
viral
replic
two
cov
cell
lower
replic
sarscov
hae
cell
might
explain
mix
cell
popul
primari
cultur
like
nonuniform
express
sarscov
receptor
contrast
cell
use
studi
clonal
popul
cell
sort
express
support
high
replic
sarscov
addit
kindler
et
al
note
absenc
induct
hpi
found
specif
upregul
hcovemc
hpi
gene
cluster
iii
upregul
sarscov
hcovemc
hpi
cluster
express
valu
de
gene
avail
http
wwwsystemsvirologyorg
data
illustr
hcovemc
sarscov
trigger
activ
pattern
recognit
receptor
may
subsequ
induc
differ
level
ifn
moreov
stark
differ
global
downstream
isg
express
follow
infect
sarscov
hcovemc
analysi
discuss
detail
elsewher
v
menacheri
et
al
submit
public
activ
similar
innat
viralsens
pathway
hcovemc
sarscov
surpris
given
conserv
mechan
detect
foreign
rna
famili
relationship
virus
also
found
virus
induc
proinflammatori
cytokin
relat
pathway
previous
shown
gene
express
exacerb
sever
respiratori
syncyti
viru
rsv
influenza
viru
infect
predict
activ
throughout
infect
hcovemc
may
induc
immunemedi
patholog
possibl
contribut
high
mortal
rate
known
produc
thelper
cell
express
cell
increas
hpi
hcovemc
infect
interestingli
produc
epitheli
cell
certain
inflammatori
condit
activ
pathway
similar
respons
increas
earlier
greater
extent
follow
hcovemc
infect
hpi
hpi
therefor
studi
respons
may
provid
interest
target
limit
lung
injuri
main
differ
respons
hcovemc
sarscov
specif
downregul
antigen
present
pathway
hcovemc
infect
contrast
gene
found
upregul
sarscov
infect
sever
virus
evolv
mechan
inhibit
mhc
class
review
refer
class
ii
review
refer
pathway
express
mhc
class
ii
usual
limit
profession
antigenpres
cell
human
lung
epitheli
cell
constitut
express
complex
data
demonstr
downregul
mhc
class
ii
transactiv
ciita
hcovemc
infect
find
possibl
explain
decreas
mhc
class
ii
molecul
express
common
viral
strategi
use
block
pathway
mhc
class
ii
inhibit
prevent
class
iimedi
present
endogen
viral
antigen
produc
within
infect
cell
impair
adapt
immun
respons
similarli
mhc
class
gene
also
downregul
hcovemc
infect
decreas
express
mhc
class
attenu
tcellmedi
recognit
infect
cell
could
allow
immun
evas
hcovemc
final
part
immunoproteasom
also
downregul
hcovemc
compon
replac
portion
standard
proteasom
enhanc
product
mhc
class
bind
peptid
absenc
protein
target
degrad
may
gener
peptid
robustli
bind
mhc
class
thu
limit
present
downregul
could
counteract
host
respons
viral
infect
includ
upregul
ubiquitin
ubiquitin
ligas
observ
hcovemc
infect
fig
may
ineffect
target
viral
protein
degrad
togeth
inhibit
mhc
class
ii
well
immunoproteasom
construct
may
import
impact
vivo
adapt
immun
respons
hcovemc
proven
effect
antivir
therapi
sarscov
sever
molecul
vitro
antivir
activ
includ
ribavirin
lopinavir
type
ifn
benefit
patient
unclear
pretreat
cell
shown
inhibit
hcovemc
replic
direct
antivir
therapi
report
target
host
factor
import
viru
instead
viru
investig
hiv
influenza
viru
exampl
inhibit
upstream
regul
control
host
respons
influenza
viru
infect
shown
reduc
viru
replic
vitro
mice
inhibit
immunophilin
interact
viral
nonstructur
protein
result
potent
inhibit
sarscov
replic
studi
character
upstream
regul
predict
activ
eg
could
target
specif
inhibitor
upstream
regul
predict
inhibit
top
five
inhibit
regul
includ
one
glucocorticoid
four
kinas
inhibitor
drug
may
abl
directli
block
part
host
respons
impact
viral
replicationpathogenesi
among
potent
inhibitor
phosphatidylinositol
kinas
known
antivir
activ
inhibit
replic
influenza
viru
vaccinia
viru
hcmv
inhibitor
mapk
also
effect
antivir
encephalomyocard
viru
rsv
hiv
also
identifi
connect
map
databas
drugassoci
gene
express
profil
molecul
revers
compon
hcovemc
gene
express
signatur
final
show
promis
antivir
result
hcovemc
sarscov
vitro
assay
fig
extens
studi
includ
doserespons
test
test
kinas
inhibitor
ongo
nonetheless
result
valid
genomebas
drug
predict
allow
rapid
identif
effect
antivir
despit
central
role
mapk
pathway
regul
multipl
cellular
process
mani
kinas
inhibitor
target
pathway
shown
safe
well
toler
vivo
review
refer
hypothes
mitogen
mapk
surviv
pathway
may
major
import
earli
develop
organ
may
dispens
adult
tissu
sever
drug
target
jnk
mek
shown
promis
therapeut
potenti
human
varieti
diseas
includ
cancer
inflammatori
disord
mapk
inhibitor
also
evalu
human
first
gener
molecul
includ
high
vivo
toxic
liver
andor
central
nervou
system
howev
develop
novel
nontox
inhibitor
eg
select
molecul
eg
administr
via
inhal
promis
strategi
use
class
inhibitor
treatment
pulmonari
diseas
overal
result
indic
kinas
inhibitor
could
use
broad
anticov
agent
might
combin
hosttarget
molecul
like
peroxisom
proliferatoractiv
receptor
agonist
better
inhibit
hcovemc
replic
conclus
use
global
gene
express
profil
shown
hcovemc
induc
dramat
host
transcript
respons
overlap
respons
induc
sarscov
studi
highlight
advantag
highthroughput
omic
global
effici
character
emerg
pathogen
robust
host
gene
express
analysi
hcovemc
infect
provid
plethora
data
mine
hypothes
understand
host
respons
profil
also
use
quickli
identifi
possibl
treatment
strategi
anticip
host
transcript
profil
becom
gener
strategi
rapid
character
futur
emerg
virus
cell
clonal
popul
cell
sort
express
grown
minimum
essenti
media
mem
gibco
supplement
fetal
bovin
serum
hyclon
antibiot
antimycot
gibco
viral
titrat
propag
hcovemc
perform
cell
use
standard
method
human
coronaviru
emc
hcovemc
receiv
bart
l
haagman
erasmu
medic
center
rotterdam
netherland
via
mta
experi
sarscov
previous
perform
condit
use
cell
work
perform
biosafeti
level
facil
support
redund
exhaust
fan
personnel
protect
equip
worn
includ
tyvek
suit
hood
hepafilt
power
airpurifi
respir
previous
describ
cell
wash
phosphatebuff
salin
pb
inocul
viru
moi
mock
dilut
pb
min
follow
inocul
cell
wash
time
fresh
medium
ad
signifi
time
zero
triplic
sampl
mockinfect
virusinfect
cell
harvest
hpi
rna
isol
cell
subsequ
hybrid
agil
human
hg
array
process
raw
data
perform
previous
describ
analyz
triplic
time
postinfect
except
hpi
one
replic
pass
rna
qualiti
control
therefor
exclud
direct
comparison
sarscovinfect
cell
raw
data
hcovemc
experi
quantil
normal
togeth
sarscov
data
set
geo
seri
access
number
probe
requir
meet
agil
featur
extract
qc
criteria
replic
least
one
infect
time
point
probe
pass
qc
filter
sampl
fold
chang
fc
valu
calcul
differ
normal
data
sampl
averag
normal
data
time
data
setmatch
mockinfect
sampl
differenti
express
determin
compar
sarscov
hcovemcinfect
replic
time
data
setmatch
mockinfect
control
base
linear
model
fit
probe
use
r
packag
limma
criteria
differenti
express
absolut
fc
q
valu
calcul
use
moder
test
subsequ
benjaminihochberg
correct
differenti
express
de
gene
hcovemc
infect
earli
time
postinfect
defin
gene
de
hpi
gene
de
late
time
postinfect
defin
gene
de
hpi
identifi
gene
similar
pattern
variat
earli
late
time
postinfect
earli
late
signatur
intersect
consid
upregul
downregul
gene
separ
combin
defin
signatur
stabl
gene
cluster
gene
de
late
time
postinfect
follow
hcovemc
infect
differenti
express
also
calcul
directli
sarscov
hcovemcinfect
sampl
use
criteria
comparison
similar
time
postinfect
perform
except
hcovemcinfect
sampl
hpi
compar
sarscov
sampl
hpi
hcovemc
sampl
hpi
compar
sar
sampl
hpi
later
time
postinfect
hpi
gene
similarli
chang
hcovemc
sarscov
cluster
ii
defin
gene
de
virus
compar
timematch
mock
also
differenti
chang
hcovemc
sarscov
least
one
previous
list
comparison
gene
cluster
iii
iv
gene
de
late
time
postinfect
follow
hcovemc
infect
similarli
chang
hcovemc
sarscov
cluster
gene
base
express
valu
hcovemc
infect
fc
valu
hpi
averag
cluster
iii
gene
averag
fc
valu
cluster
ii
iv
gene
averag
fc
valu
function
analysi
statist
signific
gene
express
chang
perform
use
ingenu
pathway
knowledg
base
ipa
ingenu
system
gene
set
enrich
analys
righttail
fisher
exact
test
use
calcul
p
valu
determin
probabl
biolog
function
assign
data
set
due
chanc
alon
enrich
score
calcul
ipa
use
probe
pass
qc
filter
background
data
set
upstream
regul
analysi
use
predict
regul
infer
activ
state
base
prior
knowledg
expect
effect
regul
known
target
gene
accord
ipa
databas
z
score
calcul
determin
whether
gene
express
chang
known
target
regul
consist
expect
literatur
z
regul
predict
activ
anticorrel
literatur
z
regul
predict
inhibit
rna
revers
transcrib
use
quantitect
revers
transcript
kit
qiagen
result
cdna
sampl
dilut
primer
set
sybr
green
quantit
rtpcr
design
use
primer
sequenc
avail
tabl
supplement
materi
rel
gene
express
infect
sampl
compar
mockinfect
cell
calcul
use
method
use
gene
calibr
express
significantli
chang
hcovemcinfect
cell
microarray
data
determin
whether
drug
revers
hcovemc
infect
signatur
use
publicli
avail
connect
map
cmap
databas
build
cmap
collect
genomewid
transcript
data
cultur
human
cell
treat
differ
compound
use
list
de
gene
stabl
infect
hcovemc
agil
probe
map
affymetrix
probe
set
use
biomart
id
convert
tool
order
queri
cmap
databas
result
filter
base
neg
connect
enrich
score
vitro
evalu
mapk
inhibitor
sigma
cell
incub
h
drug
prior
infect
hcovemc
moi
pretreat
condit
medium
replac
infect
medium
contain
ad
back
follow
inocul
posttreat
condit
cell
treat
type
ifn
uml
pbl
interferon
sourc
hpi
follow
infect
inocul
normal
matrix
express
valu
found
http
wwwsystemsvirologyorgprojecthomedata
data
set
util
cell
infect
sarscov
moi
raw
microarray
data
deposit
ncbi
gene
express
omnibu
access
number
